Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Helixate NexGen

In the US, Helixate NexGen is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

UK matches:

Ingredient matches for Helixate NexGen

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Helixate NexGen in the following countries:

  • France
  • Norway
  • Spain
  • Sweden
  • United Kingdom


SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.